Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

@article{Sharma2004HaemoglobinPS,
  title={Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.},
  author={Rakesh D. Sharma and Darrel P. Francis and Bertram Pitt and P Poole-wilson and Andrew J. Stewart Coats and Stefan D. Anker},
  journal={European heart journal},
  year={2004},
  volume={25 12},
  pages={1021-8}
}
AIMS The correction of anaemia in chronic heart failure (CHF) has been suggested to be associated with an improvement in symptoms and cardiac function. We aimed to investigate the relationship between the concentration of haemoglobin and survival in CHF. METHODS AND RESULTS We analysed haemoglobin concentrations in 3044 patients recruited in the Evaluation of Losartan In The Elderly (ELITE II) trial. Patients of mean age 71.5 +/- 6.8 years (+/-SD) and New York Heart Association (NYHA) class 2… CONTINUE READING